✦ LIBER ✦

Phase II study of fixed dose rate gemcitabine as radiosensitizer for newly diagnosed glioblastoma multiforme

✍ Scribed by Giulio Metro; Alessandra Fabi; Maria A. Mirri; Antonello Vidiri; Andrea Pace; Mariantonia Carosi; Michelangelo Russillo; Marta Maschio; Diana Giannarelli; Domenica Pellegrini; Alfredo Pompili; Francesco Cognetti; Carmine M. Carapella

Publisher: Springer
Year: 2009
Tongue: English
Weight: 312 KB
Volume: 65
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-009-1155-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fixed dose-rate gemcitabine as radiosens

Fixed dose-rate gemcitabine as radiosensitizer for newly diagnosed glioblastoma: a dose-finding study

✍ Alessandra Fabi; Alessandra Mirri; Alessandra Felici; Antonello Vidiri; Andrea P 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 172 KB

Phase II study of temozolomide and cispl

Phase II study of temozolomide and cisplatin as primary treatment prior to radiotherapy in newly diagnosed glioblastoma multiforme patients with measurable disease. A study of the Spanish Medical Neuro-Oncology Group (GENOM)

✍ Carmen Balaña; Antonio López-pousa; Alfonso Berrocal; Ricardo Yaya-tur; Ana Herr 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 158 KB